| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/13/2003 | US20030030193 Sublimating and collecting units independently controllable in temperature by electromagnetic induction heating |
| 02/13/2003 | CA2459774A1 Antivesicant compounds and methods of making and using thereof |
| 02/13/2003 | CA2456173A1 Quinoline derivatives and use thereof as antitumor agents |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2455749A1 Butyric acid derivatives |
| 02/12/2003 | EP1283202A1 Method for preparing heterocyclic-carboxylic acids |
| 02/12/2003 | EP1283199A1 Melanin-concentrating hormone antagonist |
| 02/12/2003 | EP1283055A1 Soluble beta amyloid precursor protein secretion promoters |
| 02/12/2003 | EP1282603A2 An improved process for the preparation of quinolone derivatives |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP1003724B1 Substituted quinoline derivatives with antiviral action |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
| 02/12/2003 | CN1101386C Trisubsted phenyl derivitives |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | CA2274597C Process for producing halogenated heteroaryl compounds |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010147A1 Acidic quinolone derivatives |
| 02/06/2003 | WO2003010146A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 02/06/2003 | WO2003010145A1 Biphenyl-substituted 4-hydroxy-quinolones and their use as pesticides and herbicides |
| 02/06/2003 | WO2003010144A2 A process for synthesis of fluoroquinolonic derivatives |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003010137A1 Preparation of sulfonyl quinoline |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | US20030028025 Pediatric formulation of gatifloxacin |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030027832 4-Phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP0841904B1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395507A Catalysts comprising N-substituted cyclic imides and processes for prepairing organic compounds with catalysts |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1100758C Process for preparing [(5,6-dicarboxy 3-pyridyl) methyl] ammonium halides |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515128 Dissolving 6-hydroxy-3,4-dihydroquinolinone and a base in water; dissolving a 1-cyclohexyl-5- (4-halobutyl)-tetrazole in water-immiscible solvent, mixing aqueous phase and organic phase in presence of phase transfer catalyst; recovering |
| 02/04/2003 | US6515127 The invention concerns a method for preparing quinoline-5,8-diones of formula (I) light-induced oxygenation of a 8-hydroxyquinoline. and intermediates |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6514991 Treating metabolic disorders mediated by insulin resistance or hyperglycemia; treating or inhibiting type 11 diabetes or urinary incontinence; increasing the lean meat to fat ratio in a mammal |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 02/04/2003 | US6514633 Light emitting device material, light emitting device using thereof, and amine compound |
| 01/30/2003 | WO2003007931A1 Sulfonamide derivatives |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/30/2003 | US20030022944 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/30/2003 | US20030022893 Hydroxamic and carboxylic acid derivatives |
| 01/30/2003 | US20030022868 Selective androgen receptor modulators and methods of use thereof |
| 01/29/2003 | EP1279674A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/29/2003 | CN1100039C Compound and use thereof |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511989 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 01/28/2003 | US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia |
| 01/28/2003 | US6511966 Administering for therapy of mitochondria medited disease |
| 01/23/2003 | WO2003006022A1 Tetrahydroquinoline derivatives and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/23/2003 | WO2002098367A3 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity |
| 01/23/2003 | WO2002047456A3 Urotensin-ii receptor antagonists |
| 01/23/2003 | WO2002034760A3 Compounds and methods |
| 01/23/2003 | US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018033 Antiinflammatory agents; immunology; autoimmune diseases; rheumatic diseases |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | US20030017166 Combination preparation for the therapy of immunological diseases |
| 01/22/2003 | EP1277742A1 Method for preparing halomethyl heterocyclic compounds |
| 01/22/2003 | EP1277739A1 Method for preparing heterocyclic-carboxylic acids |
| 01/22/2003 | EP1277738A1 Condensed heteroaryl derivatives |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276739A2 Heterocycles that are inhibitors of impdh enzyme |
| 01/22/2003 | EP1276732A1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 01/22/2003 | EP1276714A2 Cyclic carboxylic acids as integrin antagonists |
| 01/22/2003 | CN1099414C Method for producing fine uinoline from industrial quinoline |
| 01/21/2003 | US6509352 Selectively act on cannabinoid receptors, particularly on peripheral type cannabinoid receptors, and have fewer side effects on the central nervous system, having great immunosuppressive action, anti-inflammatory action or |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 01/16/2003 | WO2003004458A1 New compounds |
| 01/16/2003 | WO2003004028A1 Tetrahydroquinoline derivatives |
| 01/16/2003 | WO2002085857A3 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | US20030013885 Process for preparing quinolylacrylonitrile and intermediates therefor |
| 01/16/2003 | US20030013882 Recycling 1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8- methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, sulfate (gatifloxacin sulfate) |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |